Viewing Study NCT05127434


Ignite Creation Date: 2025-12-25 @ 2:38 AM
Ignite Modification Date: 2026-02-05 @ 5:33 PM
Study NCT ID: NCT05127434
Status: COMPLETED
Last Update Posted: 2025-08-19
First Post: 2021-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Evaluate the Safety and Efficacy of mRNA-1345 Vaccine Targeting Respiratory Syncytial Virus (RSV) in Adults ≥60 Years of Age
Sponsor: ModernaTX, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Respiratory Syncytial Virus View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Viral Diseases View
None Messenger RNA View
None Moderna View
None mRNA-1345 View
None Respiratory syncytial virus View
None Safety View
None Vaccines View